Search research articles
Contact Us
Filters
Showing results (131-140 of 1,622) with videos related to
Page
of 163
Sort By:
Expert Opinion on Pharmacotherapy
|
July 25, 2006
Pegylated liposomal doxorubicin in the treatment of cancers of the breast and ovary
Maurie Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2006
Normal CA-125 and the risk of progression in ovarian cancer
Maurie Markman
Current Oncology Reports
|
April 26, 2005
Chemotherapy-induced peripheral neuropathy: an increasing concern for oncologists
Maurie Markman
Journal of Cancer Research and Clinical Oncology
|
March 14, 1998
Paclitaxel as a component of initial chemotherapy of advanced ovarian cancer: is the controversy resolved
M Markman
Journal of Cancer Research and Clinical Oncology
|
January 1, 1992
Beyond palliative chemotherapy: providing hope in an era of unrealistic expectations and medical-care rationing
M Markman
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 6, 2003
Consolidation therapy revisited: intravenous chemotherapy
M Markman
Acta Medica Academica
|
July 3, 2019
Genomic-Based Therapy of Gynecologic Malignancies
Maurie Markman
Drugs
|
July 4, 2019
Pharmaceutical Management of Ovarian Cancer: Current Status
Maurie Markman
Oncology
|
March 11, 2010
Expensive cytotoxic chemotherapy in the management of advanced cancers in the developing world
Maurie Markman
Seminars in Oncology
|
October 21, 1999
Intraperitoneal chemotherapy in the management of colon cancer
M Markman
Page
of 163
Search research articles
Search
Showing results (131-140 of 1,622) with videos related to
Sort By:
Page
of 163
Expert Opinion on Pharmacotherapy
|
July 25, 2006
Pegylated liposomal doxorubicin in the treatment of cancers of the breast and ovary
Maurie Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2006
Normal CA-125 and the risk of progression in ovarian cancer
Maurie Markman
Current Oncology Reports
|
April 26, 2005
Chemotherapy-induced peripheral neuropathy: an increasing concern for oncologists
Maurie Markman
Journal of Cancer Research and Clinical Oncology
|
March 14, 1998
Paclitaxel as a component of initial chemotherapy of advanced ovarian cancer: is the controversy resolved
M Markman
Journal of Cancer Research and Clinical Oncology
|
January 1, 1992
Beyond palliative chemotherapy: providing hope in an era of unrealistic expectations and medical-care rationing
M Markman
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 6, 2003
Consolidation therapy revisited: intravenous chemotherapy
M Markman
Acta Medica Academica
|
July 3, 2019
Genomic-Based Therapy of Gynecologic Malignancies
Maurie Markman
Drugs
|
July 4, 2019
Pharmaceutical Management of Ovarian Cancer: Current Status
Maurie Markman
Oncology
|
March 11, 2010
Expensive cytotoxic chemotherapy in the management of advanced cancers in the developing world
Maurie Markman
Seminars in Oncology
|
October 21, 1999
Intraperitoneal chemotherapy in the management of colon cancer
M Markman
Page
of 163